The relationship between gender and systemic immune-inflammation index in patients with new-onset essential

Emine Altuntas1, Sükrü Cetın1, Songül Usalp1

  • 1Department of Cardiology, Sancaktepe Sehit Prof Dr Ilhan Varank Education and Research Hospital, Istanbul, Turkey.

Insights

The systemic immune-inflammation index (SII) is higher in women with hypertension and correlates with age. This finding may help improve survival rates in hypertensive women with cardiovascular diseases.

Area of Science:

  • Cardiovascular Medicine
  • Immunology
  • Gerontology

Background:

  • The systemic immune-inflammation index (SII) shows prognostic value in cardiovascular diseases and cancers.
  • Hypertension is a major risk factor for cardiovascular morbidity and mortality.

Purpose of the Study:

  • To investigate the association between SII and gender and age in newly diagnosed, treatment-naïve hypertensive patients.
  • To explore the potential of SII as a biomarker in hypertension management.

Main Methods:

  • A retrospective study of 153 newly diagnosed, treatment-naïve hypertensive patients (93 men, 60 women).
  • Calculation of SII using the formula: SII = (platelet count × neutrophil count) / lymphocyte count.
  • Analysis of SII levels in relation to gender and age.

Main Results:

  • SII was significantly higher in women than in men (546.31 vs. 385, p=0.003).
  • SII showed a positive correlation with age.
  • A specific SII cut-off value was identified for predicting new-onset essential hypertension in women with 67.6% sensitivity and 67.2% specificity.

Conclusions:

  • The study suggests a potential role for SII in differentiating hypertensive individuals based on gender and age.
  • Elevated SII in women may indicate increased inflammation and could be a marker for cardiovascular risk.
  • The findings support considering SII for improving survival rates in hypertensive women with cardiovascular diseases.
Abstract

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
71
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
66
Disorders of the Autonomic Nervous System01:18

Disorders of the Autonomic Nervous System

The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
798
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.0K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
46
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
67